These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20680537)
1. Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma. Warchoł T; Kruszyna L; Lianeri M; Roszak A; Jagodziński PP Pathol Oncol Res; 2011 Mar; 17(1):133-7. PubMed ID: 20680537 [TBL] [Abstract][Full Text] [Related]
2. The significant association of CCND1 genotypes with gastric cancer in Taiwan. Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078 [TBL] [Abstract][Full Text] [Related]
3. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis. Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525 [TBL] [Abstract][Full Text] [Related]
4. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population. Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683 [TBL] [Abstract][Full Text] [Related]
5. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk. Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195 [TBL] [Abstract][Full Text] [Related]
7. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population. Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903 [TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population. Satinder K; Chander SR; Pushpinder K; Indu G; Veena J Mol Cell Biochem; 2008 Aug; 315(1-2):151-7. PubMed ID: 18548202 [TBL] [Abstract][Full Text] [Related]
9. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570 [TBL] [Abstract][Full Text] [Related]
10. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer. Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488 [TBL] [Abstract][Full Text] [Related]
11. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer. Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS J BUON; 2013; 18(1):227-38. PubMed ID: 23613410 [TBL] [Abstract][Full Text] [Related]
12. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients. Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784 [TBL] [Abstract][Full Text] [Related]
13. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026 [TBL] [Abstract][Full Text] [Related]
14. CCND1 and CDKN1B polymorphisms and risk of breast cancer. Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061 [TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women. Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460 [TBL] [Abstract][Full Text] [Related]
16. [Impact of CCND1 A870G polymorphism on acute adverse events in postoperative rectal cancer patients treated with adjuvant concurrent chemoradiotherapy]. Qiao Y; Ren H; Huang Y; DU ZL; Yu DK; Jin J; Li YX; Lin DX; Tan W Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):268-72. PubMed ID: 23985254 [TBL] [Abstract][Full Text] [Related]
17. The significant association of CCND1 genotypes with colorectal cancer in Taiwan. Huang CY; Tsai CW; Hsu CM; Chang WS; Shui HA; Bau DT Tumour Biol; 2015 Aug; 36(8):6533-40. PubMed ID: 25809706 [TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage. Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950 [TBL] [Abstract][Full Text] [Related]
19. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Sathyan KM; Nalinakumari KR; Abraham T; Kannan S Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]